[go: up one dir, main page]

Follow
Jarno Salonen
Jarno Salonen
Department of Physics and Astronomy, University of Turku, Finland
Verified email at utu.fi
Title
Cited by
Cited by
Year
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs
J Salonen, L Laitinen, AM Kaukonen, J Tuura, M Björkqvist, T Heikkilä, ...
Journal of controlled release 108 (2-3), 362-374, 2005
6782005
Mesoporous silicon in drug delivery applications
J Salonen, AM Kaukonen, J Hirvonen, VP Lehto
Journal of pharmaceutical sciences 97 (2), 632-653, 2008
5932008
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ...
ACS nano 4 (6), 3023-3032, 2010
3842010
Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices
N Genina, J Holländer, H Jukarainen, E Mäkilä, J Salonen, N Sandler
European Journal of Pharmaceutical Sciences 90, 53-63, 2016
3582016
Mesoporous silica material TUD-1 as a drug delivery system
T Heikkilä, J Salonen, J Tuura, MS Hamdy, G Mul, N Kumar, T Salmi, ...
International journal of pharmaceutics 331 (1), 133-138, 2007
2952007
Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering
M Kaasalainen, V Aseyev, E von Haartman, DŞ Karaman, E Mäkilä, ...
Nanoscale research letters 12 (1), 74, 2017
2492017
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery
T Heikkilä, J Salonen, J Tuura, N Kumar, T Salmi, DY Murzin, MS Hamdy, ...
Drug delivery 14 (6), 337-347, 2007
2332007
The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
MA Shahbazi, M Hamidi, EM Mäkilä, H Zhang, PV Almeida, ...
Biomaterials 34 (31), 7776-7789, 2013
2312013
Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods
T Limnell, HA Santos, E Mäkilä, T Heikkilä, J Salonen, DY Murzin, ...
Journal of pharmaceutical sciences 100 (8), 3294-3306, 2011
2272011
Multistaged nanovaccines based on porous silicon@ acetalated dextran@ cancer cell membrane for cancer immunotherapy
F Fontana, MA Shahbazi, D Liu, H Zhang, E Mäkilä, J Salonen, ...
Advanced Materials 29 (7), 1603239, 2017
2262017
Fabrication and chemical surface modification of mesoporous silicon for biomedical applications
J Salonen, VP Lehto
Chemical Engineering Journal 137 (1), 162-172, 2008
2212008
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size
HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ...
Acta biomaterialia 6 (7), 2721-2731, 2010
2122010
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
LM Bimbo, E Mäkilä, T Laaksonen, VP Lehto, J Salonen, J Hirvonen, ...
Biomaterials 32 (10), 2625-2633, 2011
1942011
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution
M Sarparanta, LM Bimbo, J Rytkonen, E Makila, TJ Laaksonen, ...
Molecular pharmaceutics 9 (3), 654-663, 2012
1912012
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles
T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ...
Chemical research in toxicology 20 (12), 1913-1918, 2007
1902007
Semimetallic TiO2 Nanotubes
R Hahn, F Schmidt‐Stein, J Salonen, S Thiemann, YY Song, J Kunze, ...
Angewandte Chemie International Edition 48 (39), 7236-7239, 2009
1882009
Stabilization of porous silicon surface by thermal decomposition of acetylene
J Salonen, M Björkqvist, E Laine, L Niinistö
Applied Surface Science 225 (1-4), 389-394, 2004
1882004
Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
H Zhang, MA Shahbazi, EM Mäkilä, TH da Silva, RL Reis, JJ Salonen, ...
Biomaterials 34 (36), 9210-9219, 2013
1862013
Multifunctional porous silicon nanoparticles for cancer theranostics
CF Wang, MP Sarparanta, EM Mäkilä, MLK Hyvönen, PM Laakkonen, ...
Biomaterials 48, 108-118, 2015
1852015
The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
F Araújo, N Shrestha, MA Shahbazi, P Fonte, EM Mäkilä, JJ Salonen, ...
Biomaterials 35 (33), 9199-9207, 2014
1832014
The system can't perform the operation now. Try again later.
Articles 1–20